1. Home
  2. PRLD vs MESA Comparison

PRLD vs MESA Comparison

Compare PRLD & MESA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRLD
  • MESA
  • Stock Information
  • Founded
  • PRLD 2016
  • MESA 1982
  • Country
  • PRLD United States
  • MESA United States
  • Employees
  • PRLD N/A
  • MESA N/A
  • Industry
  • PRLD Medicinal Chemicals and Botanical Products
  • MESA Air Freight/Delivery Services
  • Sector
  • PRLD Health Care
  • MESA Consumer Discretionary
  • Exchange
  • PRLD Nasdaq
  • MESA Nasdaq
  • Market Cap
  • PRLD 73.7M
  • MESA 46.7M
  • IPO Year
  • PRLD 2020
  • MESA 2018
  • Fundamental
  • Price
  • PRLD $1.39
  • MESA $1.26
  • Analyst Decision
  • PRLD Strong Buy
  • MESA
  • Analyst Count
  • PRLD 2
  • MESA 0
  • Target Price
  • PRLD $4.50
  • MESA N/A
  • AVG Volume (30 Days)
  • PRLD 783.6K
  • MESA 255.0K
  • Earning Date
  • PRLD 02-13-2025
  • MESA 01-14-2025
  • Dividend Yield
  • PRLD N/A
  • MESA N/A
  • EPS Growth
  • PRLD N/A
  • MESA N/A
  • EPS
  • PRLD N/A
  • MESA N/A
  • Revenue
  • PRLD $3,000,000.00
  • MESA $475,518,000.00
  • Revenue This Year
  • PRLD N/A
  • MESA $15.09
  • Revenue Next Year
  • PRLD N/A
  • MESA $16.19
  • P/E Ratio
  • PRLD N/A
  • MESA N/A
  • Revenue Growth
  • PRLD N/A
  • MESA N/A
  • 52 Week Low
  • PRLD $0.80
  • MESA $0.55
  • 52 Week High
  • PRLD $6.80
  • MESA $1.89
  • Technical
  • Relative Strength Index (RSI)
  • PRLD 60.84
  • MESA 59.98
  • Support Level
  • PRLD $1.12
  • MESA $1.16
  • Resistance Level
  • PRLD $1.48
  • MESA $1.37
  • Average True Range (ATR)
  • PRLD 0.18
  • MESA 0.11
  • MACD
  • PRLD 0.05
  • MESA 0.01
  • Stochastic Oscillator
  • PRLD 74.78
  • MESA 66.67

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

About MESA Mesa Air Group Inc.

Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides scheduled passenger service to 86 cities in 36 states, the District of Columbia, Canada, Cuba, and Mexico as well as cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles and other regions.

Share on Social Networks: